These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 3589358)
1. [Use of prostaglandin E1 ovules in the therapeutic interruption of pregnancy in the 2d and 3d trimesters. Apropos of 46 cases]. Monnier JC; Caron-Grillet C; Vinatier D; Patey-Savatier P; Maunoury-Lefebvre C Rev Fr Gynecol Obstet; 1987 Mar; 82(3):195-8. PubMed ID: 3589358 [TBL] [Abstract][Full Text] [Related]
2. [A new prostaglandin E1 analog in late interruption of pregnancy, in utero deaths and very premature ruptures of the membranes. Apropos of 117 cases]. Henrion R; Oury JF; Dumez Y; Ammous A; Vige P J Gynecol Obstet Biol Reprod (Paris); 1984; 13(8):939-46. PubMed ID: 6543368 [TBL] [Abstract][Full Text] [Related]
3. [Interruption of the second and third trimester of a normal and missed pregnancy by extraamnial prostaglandin E administration combined with oxytocin infusion (author's transl)]. Havránek F; Jungmannová C Cesk Gynekol; 1979 Apr; 44(3):179-82. PubMed ID: 445588 [No Abstract] [Full Text] [Related]
4. [Antiprogesterone for medical abortion]. Khomasuridze AG; Tsertsvadze GL; Parculi MG; Parunashvili NR; Sulamanidze ShD Georgian Med News; 2006 Jun; (135):24-8. PubMed ID: 16905802 [TBL] [Abstract][Full Text] [Related]
5. Termination of normal and pathological pregnancy with Sulprostone. Fischer Z; Chwalisz K; Michałkiewicz W Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407 [TBL] [Abstract][Full Text] [Related]
6. The use of 15-methylated derivative of prostaglandin F2a for the therapeutic termination of pregnancy and management of late fetal death. Antsaklis A; Politis J; Diacomanolis E; Aravantinos D; Kaskarelis D Int Surg; 1984; 69(1):63-8. PubMed ID: 6735634 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic termination of second trimester pregnancies with low dose misoprostol. Liaquat NF; Javed I; Shuja S; Shoaib T; Bano K; Waheed S; Ansar A J Coll Physicians Surg Pak; 2006 Jul; 16(7):464-7. PubMed ID: 16827957 [TBL] [Abstract][Full Text] [Related]
8. Intraamniotic prostaglandin F2 alpha for pregnancy termination in the second and early third trimesters of pregnancy. Lipitz S; Grisaru D; Libshiz A; Rotstein Z; Schiff E; Lidor A; Achiron R J Reprod Med; 1997 Apr; 42(4):235-8. PubMed ID: 9131497 [TBL] [Abstract][Full Text] [Related]
9. [Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial]. Hidar S; Fekih M; Chaïeb A; Bibi M; Mellouli R; Khaïri H J Gynecol Obstet Biol Reprod (Paris); 2001 Sep; 30(5):439-43. PubMed ID: 11598557 [TBL] [Abstract][Full Text] [Related]
10. [Medical abortion in the second and third trimester. Report of 125 indications from 1992 to 1995]. Marret H; Perrotin F; Descamps P; de Magalhaes A; Lansac J; Body G J Gynecol Obstet Biol Reprod (Paris); 1999 Jun; 28(3):245-52. PubMed ID: 10456307 [TBL] [Abstract][Full Text] [Related]
11. [Cervix ripening and labor induction in therapeutic abortion in the middle and late 2d trimester using intracervical and extra-amniotic prostaglandin gel administration]. Rath W; Ulbrich R; Kuhn W Wien Klin Wochenschr; 1985 May; 97(11):486-93. PubMed ID: 3859953 [TBL] [Abstract][Full Text] [Related]
12. A comparative study of two types of prostaglandins for abortion during the second trimester. Rettenmaier MA; Hanson FW Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807 [TBL] [Abstract][Full Text] [Related]
14. [Place of the sulprostone in therapeutic interruptions of the pregnancy]. Khemiri B; Ben Slama A; Hsini A; Bedis Chennoufi M; Sfar E; Chelli H; Bouchnak M; Maghrebi H Tunis Med; 2007 May; 85(5):405-8. PubMed ID: 17657928 [TBL] [Abstract][Full Text] [Related]
15. [Progress in methods of therapeutical abortions during the second trimester in gynecological clinic "Umbal - Pleven"]. Stoĭkov S; Emin A; Tablov V Akush Ginekol (Sofiia); 2005; 44(4):21-6. PubMed ID: 16028374 [TBL] [Abstract][Full Text] [Related]
16. [Interruption of the late stages of pregnancy by means of transcervical amniocentesis and the replacement of the amniotic fluid]. Babukhadiia VI; Polinskaia ED; Chumanova GS; Bogdan SI Pediatr Akus Ginekol; 1974; (5):53-5. PubMed ID: 4477651 [TBL] [Abstract][Full Text] [Related]
17. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2. Hagar DL; Valley MT; Rayburn WF; Carey JC J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic termination of second trimester pregnancies with intrauterine fetal death with 400 micrograms of oral misoprostol. Pongsatha S; Tongsong T J Obstet Gynaecol Res; 2004 Jun; 30(3):217-20. PubMed ID: 15210046 [TBL] [Abstract][Full Text] [Related]
19. Termination of pregnancy in patients with missed abortion and intrauterine dead fetuses by a single intracervical application of prostaglandin E2 in viscous gel. Ekman G; Forman A; Ulmsten U; Wingerup L Zentralbl Gynakol; 1980; 102(4):219-22. PubMed ID: 7467962 [TBL] [Abstract][Full Text] [Related]
20. [Termination of pregnancy with 16,16-dimethyl-trans-delta2 PGE1 methyl ester vaginal suppositories: an analysis of 182 cases]. Du MK; Ying YD; Zheng HM; Yuan YE; Zhu Y Shengzhi Yu Biyun; 1982 Jun; 2(2):28-31. PubMed ID: 12279680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]